Press release
-
Cision PR Newswire14 April 2026
Testek Solutions Introduces ADAS 2.0: The Next Generation of Automated Aircraft Hydraulic Component Testing
New Automatic Data Acquisition System delivers faster testing, greater flexibility, and a seamless upgrade path for modern aircraft testing needs…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
Testek Solutions Introduces ADAS 2.0: The Next Generation of Automated Aircraft Hydraulic Component Testing
New Automatic Data Acquisition System delivers faster testing, greater flexibility, and a seamless upgrade path for modern aircraft testing needs…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
Lantern Partners AI Rebrands as Lantern, Expanding Its Vision and Reach
Lantern Illuminates Path to Scalable Growth NEW YORK, April 14, 2026 /PRNewswire/ — Lantern Partners AI today announced its rebranding to…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
Lantern Partners AI Rebrands as Lantern, Expanding Its Vision and Reach
Lantern Illuminates Path to Scalable Growth NEW YORK, April 14, 2026 /PRNewswire/ — Lantern Partners AI today announced its rebranding to…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
DataStrike Promotes Corey Beck to Vice President of Service Delivery
PITTSBURGH, April 14, 2026 /PRNewswire/ — DataStrike, a leader in 100 percent onshore database, cloud, and business intelligence managed services,…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
DataStrike Promotes Corey Beck to Vice President of Service Delivery
PITTSBURGH, April 14, 2026 /PRNewswire/ — DataStrike, a leader in 100 percent onshore database, cloud, and business intelligence managed services,…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
GlycoNex Receives PMDA Approval in Japan to Initiate First-in-Human Phase 1 Trial of GNX1021 in Gastrointestinal Cancers
GNX1021 is a glycan-targeting antibody-drug conjugate designed to address tumor heterogeneity in gastrointestinal cancers NEW TAIPEI CITY, Taiwan, April 14,…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
GlycoNex Receives PMDA Approval in Japan to Initiate First-in-Human Phase 1 Trial of GNX1021 in Gastrointestinal Cancers
GNX1021 is a glycan-targeting antibody-drug conjugate designed to address tumor heterogeneity in gastrointestinal cancers NEW TAIPEI CITY, Taiwan, April 14,…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
Outdated Technology Increases Risk and Impedes Mission Readiness for Federal Finance Teams, Workday Government Research Shows
Eight in Ten Respondents Say They Don’t Have the Visibility to Effectively Manage Risk Modernization Lags After Years of Piecemeal…
Read More » -
Press ReleaseCision PR Newswire14 April 2026
Outdated Technology Increases Risk and Impedes Mission Readiness for Federal Finance Teams, Workday Government Research Shows
Eight in Ten Respondents Say They Don’t Have the Visibility to Effectively Manage Risk Modernization Lags After Years of Piecemeal…
Read More »








